Ranatuerin-2PLx (1-22), R2PLx (1-22)
General Information
DRACP ID DRACP03749
Peptide Name Ranatuerin-2PLx (1-22), R2PLx (1-22)
Sequence GIMDTVKNAAKNLAGQLLDKLK
Sequence Length 22
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C102H181N29O31S
Absent amino acids CEFHPRSWY
Common amino acids KL
Mass 271659
Pl 10.33
Basic residues 4
Acidic residues 2
Hydrophobic residues 9
Net charge 2
Boman Index -2273
Hydrophobicity -15.45
Aliphatic Index 115.45
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 30279210
Title A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells
Doi Not available
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 12185